Cytokinetics (CYTK) Treasury Shares (2016 - 2023)
Historic Treasury Shares for Cytokinetics (CYTK) over the last 13 years, with Q4 2023 value amounting to $1.4 million.
- Cytokinetics' Treasury Shares rose 1320.62% to $1.4 million in Q4 2023 from the same period last year, while for Dec 2023 it was $1.4 million, marking a year-over-year increase of 1320.62%. This contributed to the annual value of $1.4 million for FY2023, which is 1320.62% up from last year.
- Latest data reveals that Cytokinetics reported Treasury Shares of $1.4 million as of Q4 2023, which was up 1320.62% from $1.2 million recorded in Q4 2022.
- Cytokinetics' 5-year Treasury Shares high stood at $1.4 million for Q4 2021, and its period low was $839075.0 during Q4 2019.
- For the 5-year period, Cytokinetics' Treasury Shares averaged around $1.2 million, with its median value being $1.2 million (2022).
- As far as peak fluctuations go, Cytokinetics' Treasury Shares soared by 5353.61% in 2019, and later plummeted by 1417.58% in 2022.
- Over the past 5 years, Cytokinetics' Treasury Shares (Quarter) stood at $839075.0 in 2019, then soared by 33.08% to $1.1 million in 2020, then rose by 26.7% to $1.4 million in 2021, then dropped by 14.18% to $1.2 million in 2022, then increased by 13.21% to $1.4 million in 2023.
- Its Treasury Shares was $1.4 million in Q4 2023, compared to $1.2 million in Q4 2022 and $1.4 million in Q4 2021.